相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma
I. Gede Putu Supadmanaba et al.
EPIGENETICS (2022)
Complex landscape of alternative splicing in myeloid neoplasms
Courtney E. Hershberger et al.
LEUKEMIA (2021)
Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias
Eleonora Makela et al.
CLINICAL CANCER RESEARCH (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness
Huijing Yin et al.
NATURE COMMUNICATIONS (2021)
Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy
Nikolay Mehterov et al.
GENES (2021)
MicroRNA miR-106a-5p targets forkhead box transcription factor FOXC1 to suppress the cell proliferation, migration, and invasion of ectopic endometrial stromal cells via the PI3K/Akt/mTOR signaling pathway
Xinyue Zhou et al.
BIOENGINEERED (2021)
Identification of HGF as a novel target of miR-15a/16/195 in gastric cancer
Dongying Liu et al.
INVESTIGATIONAL NEW DRUGS (2020)
miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database
Hsi-Yuan Huang et al.
NUCLEIC ACIDS RESEARCH (2020)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
Iris Tanaka et al.
NUCLEIC ACIDS RESEARCH (2020)
Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers
John W. Phillips et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2020)
Targeting deubiquitinating enzyme USP26 by microRNA-203 regulates Snail1's pro-metastatic functions in esophageal cancer
Gang Li et al.
CANCER CELL INTERNATIONAL (2020)
SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells
Cheng Wang et al.
COMMUNICATIONS BIOLOGY (2020)
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells
James E. Melnyk et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies
Rodney Hull et al.
CANCER MANAGEMENT AND RESEARCH (2020)
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo et al.
DRUG RESISTANCE UPDATES (2020)
HER2 splice variants in breast cancer: investigating their impact on diagnosis and treatment outcomes
Vic Hart et al.
Oncotarget (2020)
Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer
Lili Duan et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Coordinated AR and microRNA regulation in prostate cancer
Ieva Eringyte et al.
ASIAN JOURNAL OF UROLOGY (2020)
MicroRNA-mediated drug resistance in ovarian cancer
Aynaz Mihanfar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Regulation of microRNA function in animals
Luca F. R. Gebert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer
Bin Shao et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si et al.
CLINICAL EPIGENETICS (2019)
Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia
Shahrzad Pouyanrad et al.
GENE (2019)
Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab
George Pentheroudakis et al.
CLINICAL COLORECTAL CANCER (2019)
Effect of radiotherapy on the survival of cervical cancer patients An analysis based on SEER database
Jian Yang et al.
MEDICINE (2019)
Transcriptome profiling of cervical cancer cells acquired resistance to cisplatin by deep sequencing
Yamin Wang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?
Lorenzo Castagnoli et al.
CANCERS (2019)
SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression
Norihiko Kawamura et al.
CANCER RESEARCH (2019)
miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells
Junko Mukohyama et al.
CANCER RESEARCH (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells
So D. Lee et al.
CANCER SCIENCE (2019)
Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression
Mengfan Pu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
Prashanth Rawla et al.
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY (2019)
Drug resistance and combating drug resistance in cancer
Xuan Wang et al.
CANCER DRUG RESISTANCE (2019)
Emerging targets in cancer drug resistance
Shashank Kumar et al.
CANCER DRUG RESISTANCE (2019)
Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil
Maria Pereira-Oliveira et al.
BIOMOLECULES (2019)
MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/-catenin pathway
Qiang Zhang et al.
CELL BIOCHEMISTRY AND FUNCTION (2018)
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
The role of alternative splicing in cancer drug resistance
Zahava Siegfried et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer
Jian Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia
Elaheh S. Ghodousi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1
Xiaowei Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Addressing Drug Resistance in Cancer with Macromolecular Chemotherapeutic Agents
Nathaniel H. Park et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
What does not kill a tumour may make it stronger: In silico insights into chemotherapeutic drug resistance
Sara Hamis et al.
JOURNAL OF THEORETICAL BIOLOGY (2018)
MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer
Abraham Pedroza-Torres et al.
ONCOLOGY REPORTS (2018)
Functional miRNAs in breast cancer drug resistance
Weizi Hu et al.
ONCOTARGETS AND THERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4
Konstantinos Tzelepis et al.
NATURE COMMUNICATIONS (2018)
Aberrant RNA Splicing in Cancer and Drug Resistance
Bi-Dar Wang et al.
CANCERS (2018)
被撤回的出版物: MicroRNA-22 Suppresses Breast Cancer Cell Growth and Increases Paclitaxel Sensitivity by Targeting NRAS (Retracted article. See vol. 21, 2022)
Ying-kui Song et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions
Juan L. Trincado et al.
GENOME BIOLOGY (2018)
A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance
Wengong Si et al.
CELL DEATH AND DIFFERENTIATION (2018)
BCL11A mRNA Targeting by miR-210: A Possible Network Regulating γ-Globin Gene Expression
Jessica Gasparello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Reversal of multidrug resistance of leukemia cells is not necessarily induced by direct miR-138/MDR1 Rpromoter interaction
Javier T. Granados-Riveron et al.
LEUKEMIA RESEARCH (2017)
WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
Shuai Chen et al.
MOLECULAR CANCER (2017)
MicroRNA profiles involved in trifluridine resistance
Kenta Tsunekuni et al.
ONCOTARGET (2017)
MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1
Qing Xie et al.
ONCOTARGET (2017)
miR-503-5p confers drug resistance by targeting PUMA in colorectal
Ke Xu et al.
ONCOTARGET (2017)
LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
Zheng Fang et al.
CANCER MEDICINE (2017)
Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer
Cristian Rodriguez-Aguayo et al.
CELL DISCOVERY (2017)
MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway
Yuan Miao et al.
SCIENTIFIC REPORTS (2017)
被撤回的出版物: MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells (Retracted article. See vol. 56, pg. 83, 2022)
Liru Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Behzad Mansoori et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
Natural products to prevent drug resistance in cancer chemotherapy: a review
Renyikun Yuan et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
MicroRNAs are important regulators of drug resistance in colorectal cancer
Yang Zhang et al.
BIOLOGICAL CHEMISTRY (2017)
MicroRNA 21 targets BCL2 mRNA to increase apoptosis in rat and human beta cells
Emily K. Sims et al.
DIABETOLOGIA (2017)
WBP2 modulates G1/S transition in ER plus breast cancer cells and is a direct target of miR-206
Yong-qiang Ren et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3
Ju-Yeon Jeong et al.
CANCER LETTERS (2017)
Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
S. Calabretta et al.
ONCOGENE (2016)
Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML
Mohammed Dany et al.
BLOOD (2016)
Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic
Nadiya M. Teplyuk et al.
EMBO MOLECULAR MEDICINE (2016)
被撤回的出版物: Transforming Growth Factor Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer (Retracted article. See vol. 295, pg. 4368, 2020)
Yang Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
miRNA-149 promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia
Sheng-jin Fan et al.
LEUKEMIA RESEARCH (2016)
Translational control by 5′-untranslated regions of eukaryotic mRNAs
Alan G. Hinnebusch et al.
SCIENCE (2016)
MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer (vol 6, e1845, 2015)
Yang Zhang et al.
CELL DEATH & DISEASE (2016)
Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3
Xiang Ao et al.
CELL DEATH & DISEASE (2016)
Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression
Beibei Ni et al.
ONCOLOGY LETTERS (2016)
MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting β-catenin
Chun-Xu Yang et al.
ONCOLOGY LETTERS (2016)
Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations
Derya Aslan et al.
ONCOTARGET (2016)
MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
Z. Fan et al.
ONCOGENESIS (2016)
Progress in adjuvant chemotherapy for breast cancer: an overview
Jesus Anampa et al.
BMC MEDICINE (2015)
miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer
Yunhui Hu et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Khalid O. Alfarouk et al.
CANCER CELL INTERNATIONAL (2015)
MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein
Oshrat Hershkovitz-Rokah et al.
CANCER LETTERS (2015)
A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential
Suresh Kumar et al.
CURRENT DRUG TARGETS (2015)
miRNA-497 Enhances the Sensitivity of Colorectal Cancer Cells to Neoadjuvant Chemotherapeutic Drug
Lin Liu et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2015)
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
Ryo Kitagawa et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
NF-kappa B2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer
Nagalakshmi Nadiminty et al.
MOLECULAR CANCER THERAPEUTICS (2015)
NON-CODING RNA Towards a molecular understanding of microRNA-mediated gene silencing
Stefanie Jonas et al.
NATURE REVIEWS GENETICS (2015)
MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK
Dongling Zou et al.
TUMOR BIOLOGY (2015)
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Vikas Madan et al.
NATURE COMMUNICATIONS (2015)
E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter
Junjun Chu et al.
ONCOTARGET (2015)
Indirect modulation of sensitivity to 5-fluorouracil by microRNA-96 in human colorectal cancer cells
Sun-Ah Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors
Li-Sheng Wang et al.
BLOOD (2015)
Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance
Maryarn A. Hamdollah Zadeh et al.
MOLECULAR ONCOLOGY (2015)
miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
Tao Li et al.
ONCOLOGY REPORTS (2015)
MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3
Huijuan Wu et al.
ANTI-CANCER DRUGS (2014)
MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN
Xingming Ye et al.
BMB REPORTS (2014)
Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
Y. Fang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2014)
MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG
Xiao-Ping Chen et al.
CANCER LETTERS (2014)
Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
Eun Young Park et al.
CANCER RESEARCH (2014)
Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer
Dong-Xu He et al.
FEBS JOURNAL (2014)
The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer
John K. Chan et al.
GYNECOLOGIC ONCOLOGY (2014)
miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6
Xiaolan Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer
Wen-Dong Bai et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Mutant p53 Regulates Dicer through p63-dependent and -independent Mechanisms to Promote an Invasive Phenotype
Patricia A. J. Muller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
MicroRNA-23a Antisense Enhances 5-Fluorouracil Chemosensitivity Through APAF-1/Caspase-9 Apoptotic Pathway in Colorectal Cancer Cells
Jingli Shang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
Claire Corcoran et al.
MOLECULAR CANCER (2014)
miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase
Yunfei Zhou et al.
MOLECULAR ONCOLOGY (2014)
Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia
D. Allegra et al.
LEUKEMIA (2014)
The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion
C. Braeutigam et al.
ONCOGENE (2014)
miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1
Junjie Yu et al.
ONCOLOGY REPORTS (2014)
rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data
Shihao Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells
Yanqi Zhou et al.
TUMOR BIOLOGY (2014)
microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
Hao Li et al.
ONCOLOGY LETTERS (2014)
Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer
Michelle X. Liu et al.
ONCOTARGET (2014)
Splicing factor mutations and cancer
Kenichi Yoshida et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2014)
miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1
Xiaolan Zhu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
J. H. Huh et al.
BRITISH JOURNAL OF CANCER (2013)
A specific miRNA signature promotes radioresistance of human cervical cancer cells
Bin Zhang et al.
CANCER CELL INTERNATIONAL (2013)
The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
Ying Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells
Fang Wang et al.
FEBS LETTERS (2013)
miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
Chaoyang Sun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells
Ke Xu et al.
MOLECULAR CARCINOGENESIS (2013)
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Rosalind A. Eeles et al.
NATURE GENETICS (2013)
Drug rechallenge and treatment beyond progression-implications for drug resistance
Elizabeth A. Kuczynski et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1
Ge Yang et al.
ONCOLOGY REPORTS (2013)
Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate
Yajuan Li et al.
PLOS ONE (2013)
miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma
Mingli Lv et al.
PLOS ONE (2013)
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness
Helge Siemens et al.
ONCOTARGET (2013)
c-Myc modulates microRNA processing via the transcriptional regulation of Drosha
Xingwu Wang et al.
SCIENTIFIC REPORTS (2013)
Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin
J. Cai et al.
ONCOGENESIS (2013)
Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET
T. Mitamura et al.
ONCOGENESIS (2013)
Drug Resistance and the Role of Combination Chemotherapy in Improving Patient Outcomes
Denise A. Yardley
INTERNATIONAL JOURNAL OF BREAST CANCER (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
Lili Bao et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells
Naohiro Nishida et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
M. P. H. M. Jansen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
miRNA-34a is associated with docetaxel resistance in human breast cancer cells
L. Kastl et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1
Bing Feng et al.
CANCER LETTERS (2012)
MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition
Yemin Wang et al.
CANCER RESEARCH (2012)
Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells
Marisa Meyers-Needham et al.
EMBO MOLECULAR MEDICINE (2012)
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
Xin Fu et al.
FEBS LETTERS (2012)
Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1
Chun Yang et al.
GYNECOLOGIC ONCOLOGY (2012)
Effect of all-trans retinoic acid (ATRA) on syndecan-1 expression and its chemoprotective effect in benzo(α) pyrene-induced lung cancer mice model
D. Ramya et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2012)
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
Benjamin Boyerinas et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy
Zhenyou Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
Diana M. Cittelly et al.
MOLECULAR CANCER THERAPEUTICS (2012)
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
F. Damm et al.
LEUKEMIA (2012)
Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance
Lingyun Yang et al.
ONCOLOGY REPORTS (2012)
Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
Hongjiang Wang et al.
PLOS ONE (2012)
miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
Florian Kopp et al.
PLOS ONE (2012)
MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression
Eleonora Turrini et al.
PHARMACOGENETICS AND GENOMICS (2012)
The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer
Tong Sun et al.
PROSTATE (2012)
miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines
Huijuan Chai et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
MicroRNAs-10a and-10b Contribute to Retinoic Acid-induced Differentiation of Neuroblastoma Cells and Target the Alternative Splicing Regulatory Factor SFRS1 (SF2/ASF)
Salvador Meseguer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
Bin Xu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia
Hua Zhang et al.
MOLECULAR CANCER (2011)
The ATM Kinase Induces MicroRNA Biogenesis in the DNA Damage Response
Xinna Zhang et al.
MOLECULAR CELL (2011)
let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast Cancer
Yingchun Zhao et al.
MOLECULAR MEDICINE (2011)
Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer
O. Arrieta et al.
NEUROLOGY (2011)
MicroRNA-451 Is Involved in the Self-renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells
Nerea Bitarte et al.
STEM CELLS (2011)
A Genetic Defect in Exportin-5 Traps Precursor MicroRNAs in the Nucleus of Cancer Cells
Sonia A. Melo et al.
CANCER CELL (2010)
MicroRNA and drug resistance
J. Ma et al.
CANCER GENE THERAPY (2010)
MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression.
Yasunori Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Xiaohua Su et al.
NATURE (2010)
Analysis and design of RNA sequencing experiments for identifying isoform regulation
Yarden Katz et al.
NATURE METHODS (2010)
miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor
Nora E. Renthal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
Nicola Valeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MiR-34a Attenuates Paclitaxel-Resistance of Hormone-Refractory Prostate Cancer PC3 Cells Through Direct and Indirect Mechanisms
Keitaro Kojima et al.
PROSTATE (2010)
RNAcontext: A New Method for Learning the Sequence and Structure Binding Preferences of RNA-Binding Proteins
Hilal Kazan et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
Dawn R. Cochrane et al.
JOURNAL OF ONCOLOGY (2010)
Therapeutic Nanoparticles to Combat Cancer Drug Resistance
Che-Ming Jack Hu et al.
CURRENT DRUG METABOLISM (2009)
miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA
Deo Prakash Pandey et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
Dawn R. Cochrane et al.
MOLECULAR CANCER THERAPEUTICS (2009)
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
Bob Lowenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MEME SUITE: tools for motif discovery and searching
Timothy L. Bailey et al.
NUCLEIC ACIDS RESEARCH (2009)
Reprogramming of 3′ Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types
Zhe Ji et al.
PLOS ONE (2009)
The impact of microRNAs and alternative splicing in pharmacogenomics
F. Passetti et al.
PHARMACOGENOMICS JOURNAL (2009)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA
William Kong et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The impact of microRNAs on protein output
Daehyun Baek et al.
NATURE (2008)
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
William M. Merritt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites
Rickard Sandberg et al.
SCIENCE (2008)
Two isoforms of the T-cell intracellular antigen 1 (TIA-1) splicing factor display distinct splicing regulation activities -: Control of TIA-1 isoform ratio by TIA-1-related protein
Jose M. Izquierdo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer
Kathleen N. Moore et al.
GYNECOLOGIC ONCOLOGY (2007)
Retained introns increase putative microRNA targets within 3′ UTRs of human mRNA
Sheng Tan et al.
FEBS LETTERS (2007)
Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors
Keith Woods et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The role of radiotherapy in cancer treatment - Estimating optimal utilization from a review of evidence-based clinical guidelines
G Delaney et al.
CANCER (2005)
Reduced expression of Dicer associated with poor prognosis in lung cancer patients
Y Karube et al.
CANCER SCIENCE (2005)
In search of antisense
G Lavorgna et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
NF1 exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis 1 patient
P Colapietro et al.
HUMAN GENETICS (2003)
Strategies for reversing drug resistance
T Fojo et al.
ONCOGENE (2003)
Alternative pre-mRNA splicing and proteome expansion in metazoans
T Maniatis et al.
NATURE (2002)
A hMLH1 genomic mutation and associated novel mRNA defects in a hereditary non-polyposis colorectal cancer family
Q Tanko et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2002)
Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells
MJT Veuger et al.
BLOOD (2002)
分享论文
